The flaviviruses contain many pathogens of public health importance, including dengue virus (DENV) and West Nile virus (WNV) for which we have no licensed vaccines. Live attenuated vaccines, which induce durable protective immunity, are one of the important strategies to control flavivirus diseases and have been very successful at controlling yellow fever (YF) and Japanese encephalitis (JE). The nonstructural (NS) proteins are associated with evasion of host innate immunity. Among them, NS4B protein has extensive homology between flaviviruses and the N-terminal region has been shown to encode a major interferon (IFN) antagonism function. Thus, we focus on NS4B to identify stable mutations that can be used to rationally attenuate candidate live flavivirus vaccines. We are using WNV as a model and have identified two highly attenuated WNV NS4B mutants. The C102S mutant has a substitution in the flavivirus conserved central hydrophobic domain of NS4B protein, which is known to contribute to the virulence phenotype of flaviviruses, and contains mutations in the attenuated derivatives of YFV, JEV and DENV. Although the NS4B-C102S mutant was highly attenuated for mouse neuroinvasiveness and neurovirulence, and conferred protective immunity in mice, it was prone to reversion. It is not an ideal candidate vaccine by itself. Another attenuated WNV mutant has a substitution in the highly conserved P38 residue in the N-terminal region of the NS4B protein. It is highly attenuated for mouse neuroinvasiveness, highly immunogenic, reversion of the mutant has not been identified. Our recent published work showed that the NS4B-P38G mutant induced higher innate cytokine and memory T cell responses in mice than the wild-type (WT) NY99 strain, and immunized mice were all protected from WT WNV challenge. The underlying immune mechanisms are not clearly understood. We hypothesize that the P38G substitution in the IFN antagonism region or in combination with mutation(s) in the conserved central hydrophobic region of WNV NS4B protein will confer an attenuated phenotype and the ability to induce higher protective immunity than WT NY99, and this may serve as an excellent model to develop potential live flavivirus vaccine candidate(s). We will first elucidate the immune mechanisms by which WNV NS4B-P38G mutant triggers higher protective immunity than WT NY99. We will next determine whether incorporating the NS4B-C102S mutation will further enhance and stabilize the attenuated phenotype of WNV NS4B-P38G mutant. Lastly, we will characterize immune responses to WNV NS4B-P38G/C102S double mutant infection in mouse and human cells and evaluate the protective effects of WNV NS4B mutant strains after immunization of mice followed by lethal WT WNV challenge. Characterization of stable mutations in the highly conserved coding regions of WNV NS4B protein and investigation the mechanism by which WNV NS4B mutant induces higher protective immunity can be utilized as a paradigm to aid in the rational development of other efficacious live attenuated flavivirus vaccines.
Development of safe and effective vaccines for West Nile virus (WNV) in humans remains a high priority. In this project, we focus on two highly conserved coding regions of WNV nonstructural (NS) 4B protein to identify stable mutations that can be used to rationally attenuate candidate live flavivirus vaccines. Characterization of stable WNV NS4B mutants and investigation the mechanism by which these attenuated WNV NS4B mutants induce higher protective immunity can be utilized as a paradigm to aid in the rational development of other efficacious live attenuated flavivirus vaccines.
|Li, Guangyu; Teleki, Cody; Wang, Tian (2018) Memory T Cells in Flavivirus Vaccination. Vaccines (Basel) 6:|
|Luo, Huanle; Wang, Tian (2018) Recent advances in understanding West Nile virus host immunity and viral pathogenesis. F1000Res 7:338|
|Luo, Huanle; Winkelmann, Evandro R; Fernandez-Salas, Ildefonso et al. (2018) Zika, dengue and yellow fever viruses induce differential anti-viral immune responses in human monocytic and first trimester trophoblast cells. Antiviral Res 151:55-62|
|Xia, Hongjie; Luo, Huanle; Shan, Chao et al. (2018) An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction. Nat Commun 9:414|
|Zou, Jing; Xie, Xuping; Luo, Huanle et al. (2018) A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity. EBioMedicine 36:92-102|
|Luo, Huanle; Winkelmann, Evandro R; Zhu, Shuang et al. (2018) Peli1 facilitates virus replication and promotes neuroinflammation during West Nile virus infection. J Clin Invest 128:4980-4991|
|Kaiser, Jaclyn A; Wang, Tian; Barrett, Alan Dt (2017) Virulence determinants of West Nile virus: how can these be used for vaccine design? Future Virol 12:283-295|
|Luo, Huanle; Winkelmann, Evandro; Xie, Guorui et al. (2017) MAVS Is Essential for Primary CD4+ T Cell Immunity but Not for Recall T Cell Responses following an Attenuated West Nile Virus Infection. J Virol 91:|
|Saxena, Vandana; Bolling, Bethany G; Wang, Tian (2017) West Nile Virus. Clin Lab Med 37:243-252|
|Zhu, Shuang; Luo, Huanle; Liu, Hua et al. (2017) p38MAPK plays a critical role in induction of a pro-inflammatory phenotype of retinal Müller cells following Zika virus infection. Antiviral Res 145:70-81|
Showing the most recent 10 out of 16 publications